Equities

Chongqing Taiji Industry Group Co Ltd

600129:SHH

Chongqing Taiji Industry Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)24.60
  • Today's Change-1.16 / -4.50%
  • Shares traded11.81m
  • 1 Year change-44.51%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Chongqing Taiji Industry Group Co Ltd grew revenues 10.58% from 14.13bn to 15.62bn while net income improved 131.99% from 354.38m to 822.12m.
Gross margin42.31%
Net profit margin4.60%
Operating margin5.57%
Return on assets4.46%
Return on equity15.59%
Return on investment12.44%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Chongqing Taiji Industry Group Co Ltd fell by 319.71m. However, the company earned 671.54m from its operations for a Cash Flow Margin of 4.30%. In addition the company used 627.08m on investing activities and also paid 363.61m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share7.18
Tangible book value per share4.55
More ▼

Balance sheet in CNYView more

Chongqing Taiji Industry Group Co Ltd has a Debt to Total Capital ratio of 55.28%, a higher figure than the previous year's 20.60%.
Current ratio0.7889
Quick ratio0.4665
Total debt/total equity1.27
Total debt/total capital0.5528
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.